Ibsrela (tenapanor) — United Healthcare
irritable bowel syndrome with constipation
Initial criteria
- Diagnosis of irritable bowel syndrome with constipation
Reauthorization criteria
- Documentation of positive clinical response to therapy
Approval duration
12 months